clinical trial · NCT06494397
Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions
SchizophreniaBipolar I DisorderVHX-896 and iloperidoneIloperidone and VHX-896
brief summary
Study to compare the pharmacokinetics and pharmacodynamics of VHX-896 and iloperidone and evaluate the safety and tolerability of VHX-896 and iloperidone in patients with schizophrenia or bipolar I disorder under steady state conditions.
started
Jul 11, 2024
primary completion
Oct 24, 2024
completion
Oct 24, 2024
last updated
Sep 19, 2025
official title
Crossover Bioequivalence Study of 12 mg VHX-896 and Iloperidone Tablets Under Steady-State Conditions
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol